DeDora Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$14.5K Buy
+242
New +$15.2K ﹤0.01% 277
2022
Q2
– Sell
-81
Closed -$6K – 139
2022
Q1
$6K Buy
+81
New +$6.78K ﹤0.01% 334

Other funds holding BMRN

DeDora Capital's BMRN Position: Q3 2026 in Review

DeDora Capital opened a new position in BioMarin Pharmaceuticals (BMRN) in Q3 2026: 242 shares worth $14.5K. The stake represents ﹤0.01% of the portfolio and ranks #277 among its holdings. This is a return to the name: DeDora Capital previously reported a position in BMRN as recently as Q1 2022.

DeDora Capital first reported a position in BMRN in Q1 2022 and has held it in 2 quarters since. 567 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.

  • DeDora Capital held 242 shares of BioMarin Pharmaceuticals worth $14.5K as of Q3 2026.
  • BioMarin Pharmaceuticals was a new DeDora Capital position in Q3 2026.
  • BioMarin Pharmaceuticals made up ﹤0.01% of DeDora Capital's portfolio in Q3 2026, its #277 holding.
  • DeDora Capital first reported a position in BioMarin Pharmaceuticals in Q1 2022 and has held it in 2 quarters since.
  • 567 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.

Based on DeDora Capital's 13F filing for Q3 2026, filed 26 Oct 2026.